LINRODOSTAT: 66 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
66
Total FAERS Reports
13 (19.7%)
Deaths Reported
62
Hospitalizations
66
As Primary/Secondary Suspect
12
Life-Threatening
1
Disabilities
Active Ingredient: LINRODOSTAT MESYLATE ·
First Report: 20170613 · Latest Report: 20220118
What Are the Most Common LINRODOSTAT Side Effects?
#1 Most Reported
Malignant neoplasm progression
4 reports (6.1%)
#2 Most Reported
Troponin increased
3 reports (4.5%)
#3 Most Reported
Sepsis
3 reports (4.5%)
All LINRODOSTAT Side Effects by Frequency
No side effect data available.
Who Reports LINRODOSTAT Side Effects? Age & Gender Data
Gender: 22.1% female, 77.9% male. Average age: 65.9 years. Most reports from: FR. View detailed demographics →
Is LINRODOSTAT Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 2 | 1 | 2 |
| 2018 | 7 | 1 | 7 |
| 2019 | 11 | 3 | 9 |
| 2020 | 22 | 6 | 21 |
| 2021 | 22 | 2 | 22 |
| 2022 | 2 | 0 | 1 |
What Is LINRODOSTAT Used For?
| Indication | Reports |
|---|---|
| Bladder cancer | 22 |
| Malignant melanoma | 16 |
| Glioblastoma | 6 |
| Head and neck cancer | 5 |
Official FDA Label for LINRODOSTAT
Official prescribing information from the FDA-approved drug label.